The buildout of a 63,000-square-foot Framingham facility by Woburn biotech Replimune is on schedule, with the company having received an occupancy permit and begun transferring technology to the site.
The company reported the progress in its third quarter financial update, where it reported out positive results for clinical trials. The facility in Framingham would be used to support full commercialization of the company’s product candidates.
The company’s facility will take up more than half of the 100,000-square-foot building at 33 New York Ave., formerly the home of the MetroWest Daily News.Â
